Kenvue Inc. $KVUE Stock Holdings Decreased by SG Americas Securities LLC

SG Americas Securities LLC lowered its position in shares of Kenvue Inc. (NYSE:KVUE) by 55.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 77,088 shares of the company’s stock after selling 97,712 shares during the quarter. SG Americas Securities LLC’s holdings in Kenvue were worth $1,251,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in KVUE. Norges Bank purchased a new stake in shares of Kenvue during the second quarter worth $537,418,000. Independent Franchise Partners LLP grew its stake in Kenvue by 233.4% in the second quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock valued at $654,388,000 after purchasing an additional 21,886,537 shares in the last quarter. American Century Companies Inc. increased its position in Kenvue by 38.6% in the 2nd quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock worth $633,447,000 after purchasing an additional 8,436,166 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in shares of Kenvue by 770.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 7,697,023 shares of the company’s stock worth $161,099,000 after purchasing an additional 6,812,675 shares in the last quarter. Finally, Amundi raised its stake in shares of Kenvue by 82.5% during the 2nd quarter. Amundi now owns 14,509,890 shares of the company’s stock worth $305,446,000 after purchasing an additional 6,559,261 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The stock was bought at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the transaction, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. This represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 1.68% of the stock is currently owned by insiders.

Analyst Ratings Changes

KVUE has been the subject of several recent research reports. Barclays boosted their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. UBS Group decreased their price objective on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $18.00 target price on shares of Kenvue in a research report on Friday, October 24th. Rothschild & Co Redburn raised Kenvue from a “neutral” rating to a “buy” rating and reduced their price target for the stock from $22.50 to $22.00 in a research report on Friday, September 26th. Finally, Rothschild Redb upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 26th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and twelve have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $20.23.

Kenvue Stock Performance

NYSE KVUE opened at $17.20 on Friday. The stock has a market cap of $32.95 billion, a P/E ratio of 22.93 and a beta of 0.60. The company’s 50-day simple moving average is $16.97 and its 200 day simple moving average is $18.29. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. During the same quarter in the prior year, the firm earned $0.28 EPS. The firm’s quarterly revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Investors of record on Wednesday, November 12th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date was Wednesday, November 12th. Kenvue’s dividend payout ratio (DPR) is presently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.